SCHEMBL975780

SCHEMBL975780

[Ni+2].[Ni+2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[Ta+5].[Ta+5]

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
KDM3A Q9Y4C1 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29439938 1.00
Lithium Ion SCHEMBL21112992 0.87
SCHEMBL29388977 0.87
SCHEMBL17784480 0.87
SCHEMBL1902881 0.82
SCHEMBL11654272 0.82
SCHEMBL9700329 0.82 KDM3A (0.50) KDM3A
SCHEMBL21802721 0.82 KDM3A (0.50) KDM3A
SCHEMBL139857 0.82
SCHEMBL31368627 0.82

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 184 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2089764-B1 METHOD OF MAKING AN ION-SWITCHING DEVICE WITHOUT A SEPARATE LITHIATION STEP SAGE ELECTROCHROMICS INC (US) 2016-01-06 EP claimed
US-7830585-B2 Method of making an ion-switching device without a separate lithiation step SAGE ELECTROCHROMICS, INC. (US) 2010-11-09 US claimed
US-20100007937-A1 METHOD OF MAKING AN ION-SWITCHING DEVICE WITHOUT A SEPARATE LITHIATION STEP SAGE ELECTROCHROMICS, INC. 2010-01-14 US claimed
EP-2089764-A1 METHOD OF MAKING AN ION-SWITCHING DEVICE WITHOUT A SEPARATE LITHIATION STEP Sage Electrochromics, Inc. (US) 2009-08-19 EP claimed
WO-2008055824-A1 METHOD OF MAKING AN ION-SWITCHING DEVICE WITHOUT A SEPARATE LITHIATION STEP SAGE ELECTROCHROMICS, INC. (US) 2008-05-15 WO claimed
US-6859297-B2 Electrochromic counter electrode MIDWEST RESEARCH INSTITUTE (US) 2005-02-22 US claimed
US-20040150867-A1 Electrochromic counter electrode ALLIANCE FOR SUSTAINABLE ENERGY, LLC 2004-08-05 US claimed
WO-2003014254-A1 ELECTROCHROMIC COUNTER ELECTRODE MIDWEST RESEARCH INSTITUTE (US) 2003-02-20 WO claimed
US-12631926-B2 Counter electrode for electrochromic devices VIEW OPERATING CORPORATION (US) 2026-05-19 US disclosed
US-20260079374-A1 CONTROLLERS FOR OPTICALLY SWITCHABLE DEVICES VIEW OPERATING CORPORATION (US) 2026-03-19 US disclosed
US-12572047-B2 Fabrication of electrochromic devices VIEW OPERATING CORPORATION (US) 2026-03-10 US disclosed
US-20260038499-A1 CONTROLLING OPTICALLY-SWITCHABLE DEVICES VIEW OPERATING CORPORATION (US) 2026-02-05 US disclosed
US-20260016728-A1 COUNTER ELECTRODE FOR ELECTROCHROMIC DEVICES VIEW OPERATING CORPORATION (US) 2026-01-15 US disclosed
US-20250383573-A1 CONTROLLERS FOR OPTICALLY-SWITCHABLE DEVICES VIEW OPERATING CORPORATION (US) 2025-12-18 US disclosed
WO-2009115424-A1 A LIGHT WEIGHT ELECTROCHROMIC MIRROR STACK NV BEKAERT SA (BE) 2009-09-24 WO disclosed
EP-2089764-A1 METHOD OF MAKING AN ION-SWITCHING DEVICE WITHOUT A SEPARATE LITHIATION STEP Sage Electrochromics, Inc. (US) 2009-08-19 EP disclosed
WO-2008055824-A1 METHOD OF MAKING AN ION-SWITCHING DEVICE WITHOUT A SEPARATE LITHIATION STEP SAGE ELECTROCHROMICS, INC. (US) 2008-05-15 WO disclosed
US-6859297-B2 Electrochromic counter electrode MIDWEST RESEARCH INSTITUTE (US) 2005-02-22 US disclosed
US-20040150867-A1 Electrochromic counter electrode ALLIANCE FOR SUSTAINABLE ENERGY, LLC 2004-08-05 US disclosed
WO-2003014254-A1 ELECTROCHROMIC COUNTER ELECTRODE MIDWEST RESEARCH INSTITUTE (US) 2003-02-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12572047-B2 Fabrication of electrochromic devices L3MBTL3, EED, AGO2 KDM3A 2295/4885
US-20260016728-A1 COUNTER ELECTRODE FOR ELECTROCHROMIC DEVICES WNT3A, WNT3, WNK3 KDM3A 765/4885
US-20260079374-A1 CONTROLLERS FOR OPTICALLY SWITCHABLE DEVICES IGLV6-57, IGSF11, ICOS KDM3A 2652/4885
US-20260038499-A1 CONTROLLING OPTICALLY-SWITCHABLE DEVICES CHRM4, EPHA4, EPHA3 KDM3A 1041/4885
US-12631926-B2 Counter electrode for electrochromic devices WNT3, HCN3, HCN2 KDM3A 935/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.